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Abstract
Background: Although the acute toxicity of organophosphorus nerve agents is known to result from
acetylcholinesterase inhibition, the molecular mechanisms involved in the development of neuropathology
following nerve agent-induced seizure are not well understood. To help determine these pathways, we previously
used microarray analysis to identify gene expression changes in the rat piriform cortex, a region of the rat brain
sensitive to nerve agent exposure, over a 24-h time period following sarin-induced seizure. We found significant
differences in gene expression profiles and identified secondary responses that potentially lead to brain injury and
cell death. To advance our understanding of the molecular mechanisms involved in sarin-induced toxicity, we
analyzed gene expression changes in four other areas of the rat brain known to be affected by nerve agent-
induced seizure (amygdala, hippocampus, septum, and thalamus).
Methods: We compared the transcriptional response of these four brain regions to sarin-induced seizure with the
response previously characterized in the piriform cortex. In this study, rats were challenged with 1.0 × LD50 sarin
and subsequently treated with atropine sulfate, 2-pyridine aldoxime methylchloride, and diazepam. The four brain
regions were collected at 0.25, 1, 3, 6, and 24 h after seizure onset, and total RNA was processed for microarray
analysis.
Results: Principal component analysis identified brain region and time following seizure onset as major sources of
variability within the dataset. Analysis of variance identified genes significantly changed following sarin-induced
seizure, and gene ontology analysis identified biological pathways, functions, and networks of genes significantly
affected by sarin-induced seizure over the 24-h time course. Many of the molecular functions and pathways
identified as being most significant across all of the brain regions were indicative of an inflammatory response.
There were also a number of molecular responses that were unique for each brain region, with the thalamus
having the most distinct response to nerve agent-induced seizure.
Conclusions: Identifying the molecular mechanisms involved in sarin-induced neurotoxicity in these sensitive brain
regions will facilitate the development of novel therapeutics that can potentially provide broad-spectrum
protection in five areas of the central nervous system known to be damaged by nerve agent-induced seizure.
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Organophosphorus (OP) nerve agents, such as sarin (O-
isopropyl methylphosphonofluoridate), irreversibly inhi-
bit the enzyme acetylcholinesterase (AChE). This inacti-
vation of AChE causes a toxic accumulation of the
neurotransmitter acetylcholine (ACh) and results in
over-stimulation of muscarinic and nicotinic ACh recep-
tors [1-3]. Due to the continuous stimulation of mus-
cles, glands, and central nervous system, victims
exposed to these poisonous agents develop myosis, tigh-
tening of the chest, difficulty breathing, and a general
loss of bodily functions. As symptoms progress, the vic-
tims suffer from convulsive spasms and seizures that
can quickly progress to status epilepticus (SE), which
has been strongly associated with brain damage in survi-
vors, and death [1,3-6].
Current medical countermeasures against toxic levels
of nerve agents can increase survival if administered
within a short period of time following exposure, but
they may not fully prevent neuropathology or functional
impairment [3,6-9]. Although these countermeasures are
readily available to soldiers in a combat setting, they are
not accessible to the general public in case of a terrorist
attack. The anticipated response time to treat civilian
casualties exposed to nerve agent is estimated to be at
least 30 min [6], and many will have already initiated
seizures by the time medical personnel arrive. Rapidly
terminating nerve agent-induced seizures is critical
because their duration and intensity have been directly
linked to brain damage following exposure [4,10-12].
Previous studies have shown signs of neuropathology
present within 20 min of seizure onset and have demon-
strated the increased difficulty in terminating seizures
lasting beyond 40 min [6,10]. Therefore, it is important
to understand the mechanism of nerve agent-induced
brain injury and identify treatments that are effective
when administered after the initiation of seizures and
the secondary responses that lead to brain injury.
We previously characterized the transcriptional
response of rat piriform cortex following sarin exposure
[51]. We found that critical gene expression profile dif-
ferences correlated with seizure induction and identified
secondary responses that potentially lead to brain injury
and cell death. In addition to the piriform cortex, other
brain regions have been identified as sensitive to varying
degrees to nerve agent exposure. These include the
amygdala, hippocampus, septum, and thalamus
[3,6,10,13]. To understand in greater detail the molecu-
lar responses of these brain regions to nerve agent, we
utilized oligonucleotide microarrays to define the tem-
poral transcriptional responses of these brain regions
following sarin-induced seizure in a rat model. We then
compared the transcriptional profiles of these four brain
regions to the transcriptional response previously char-
acterized in the piriform cortex to identify the common
and unique molecular mechanisms significantly affected
by sarin-induced seizure in these five sensitive brain
regions.
Methods
Sarin exposure
Male Sprague-Dawley rats (350-500 g) were obtained
from Charles River Laboratories (Wilmington, MA).
They were housed in a temperature-controlled room
with a 12-h light/12-h dark cycle and given food and
water ad libitum. The research for this study was con-
ducted at the United States Army Medical Research
Institute of Chemical Defense (USAMRICD; Aberdeen
Proving Ground, MD), which is fully accredited by the
Association for Assessment and Accreditation of
Laboratory Animal Care, International. All of the animal
procedures were approved by the Institute Animal Care
and Use Committee at USAMRICD and conducted in
accordance with the principles stated in the Guide for
t h eC a r ea n dU s eo fL a b o r a t o r yA n i m a l s(National
Research Council, 1996) and the Animal Welfare Act of
1966 (P.L. 89-544), as amended.
PhysioTel
® F40-EET transmitters (Data Sciences
International, St. Paul, MN) were surgically implanted
into the animals to record bi-hemispheric cortical elec-
troencephalogram (EEG) activity, body temperature, and
gross motor activity throughout the study. After a two-
week recovery period, the animals were challenged with
1×L D 50 sarin (108 μg/kg, sc) that was obtained and
diluted in sterile saline at USAMRICD. One minute
after seizure onset, animals were treated with atropine
sulfate (2 mg/kg; Sigma-Aldrich, St. Louis, MO) and 2-
pyridine aldoxime methylchloride (2-PAM; 25 mg/kg;
Sigma-Aldrich), both administered in a single injection
(im). Thirty minutes later, animals used for the 1-h to
24-h time points were given the anticonvulsant diaze-
pam (10 mg/kg, sc; TW Medical Veterinary Supply,
Austin, TX). Control animals received an equivalent
volume of vehicle (saline), atropine sulfate, 2-PAM, and
diazepam. Naïve animals received no injections.
Behavioral observations were documented for each
animal following exposure and placed in one of three
categories (mild, moderate, or severe). The total was
then calculated and graphed using the total number of
toxic signs listed in the moderate (e.g., loss of posture,
excessive salivation and/or lacrimation, and body tre-
mors) and severe (e.g., complete loss of posture, clonic-
tonic convulsions, and gasping) categories. These beha-
vioral observations corresponded with the five stages of
behavioral seizure intensity, which were rated using a
modified Racine scale score [14]: stage 0 = baseline
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sleeping; stage 1 = inactivity, unusual posture, piloerec-
tion, frozen posture, clumsy motion, and excessive
grooming or chewing; stage 2 = oral tonus, head bobs,
and body tremors; stage 3 = forelimb myoclonus, pros-
trate body extension, and salivation or lacrimation; stage
4 = loss of posture, whole body tremors, rigidity, body
jerks, and forelimb myoclonus followed by rearing; and
stage 5 = complete loss of posture, falling or generalized
tonic-clonic convulsions, and gasping. Statistical signifi-
cance between sarin-exposed seizing animals and their
controls was calculated using Student’s t-test.
Animals were euthanized by decapitation at 0.25, 1, 3,
6, and 24 h after seizure onset. The amygdala, hippo-
campus, septum, and thalamus were immediately col-
lected from each animal at the appropriate time point.
Three animals were used for each experimental group
(naïve, saline control, and sarin-exposed seizure) at each
time point, with the exception of 1-h saline control, 3-h
sarin-exposed seizure, and 24-h sarin-exposed seizure (n
= 4). Each tissue was immediately snap-frozen in liquid
nitrogen and stored at -80°C until use.
Sample preparation for microarray hybridization
Brain tissues were homogenized in RNeasy lysis buffer
(QIAGEN, Valencia, CA) at three intervals of 30 sec
each using the Mini-Beadbeater-96 (Biospec Products,
Bartlesville, OK) and 6.35 mm stainless steel beads.
Each homogenate was subsequently centrifuged for 10
min at 16,110 × g at room temperature, and the super-
natant was transferred to a new microcentrifuge tube.
Total RNA was then extracted and DNase I-treated
using the RNeasy Mini Kit and RNase-Free DNase Set
(QIAGEN) according to the manufacturer’sp r o t o c o l .
The quantity and quality of the RNA was determined
with a NanoDrop ND-1000 UV-vis spectrophotometer
(Thermo Scientific, Wilmington, DE) and an Agilent
Bioanalyzer (Agilent Technologies, Santa Clara, CA)
throughout sample processing. Total RNA was pro-
cessed for hybridization to GeneChip
® R a tG e n o m e2 3 0
2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara,
CA) using the BioArray Single-Round RNA Amplifica-
tion and Biotin Labeling System (Enzo Life Sciences,
Inc., Farmingdale, NY) as previously described [15]. In
brief, 1 μg (amygdala, hippocampus, and thalamus) or
500 ng (septum) of total RNA was used to generate first
strand cDNA by using a T7-linked oligo(dT) primer.
After second strand synthesis, in vitro transcription was
performed with biotinylated UTP and CTP for cRNA
amplification. Biotinylated target cRNA generated from
each sample was processed according to the manufac-
turer’s protocol using an Affymetrix GeneChip Instru-
ment System http://affymetrix.com/support/ technical/
manual/expression_manual.affx as previously described
[15].
All microarray experiments were performed to comply
with Minimal Information About a Microarray Experi-
ment (MIAME) protocols and details can be found at
the Gene Expression Omnibus (GEO) accessible through
GEO Series accession number GSE28435. The data dis-
cussed in this publication have been deposited in the
National Center for Biotechnology Information’sG e n e
Expression Omnibus (GEO; http://www.ncbi.nlm.nih.
gov/geo/) and are accessible through GEO
Series accession number GSE28435.
Microarray data analysis
Raw signal intensities from each GeneChip
® were
imported into Partek Genomics Suite v6.4 (Partek, Inc.,
St. Louis, MO) along with those from the piriform cor-
tex samples [51]. The signal intensities were normalized
using the robust multiarray averaging (RMA) algorithm
[16]. Normalized data for all five brain regions (amyg-
dala, hippocampus, piriform cortex, septum, and thala-
mus) were analyzed by principal component analysis
(PCA) [17] to identify patterns in the dataset and high-
light similarities and differences among the samples.
The major sources of variability identified within the
dataset were used as grouping variables for analysis of
variance (ANOVA). The calculated p-value and geo-
metric fold change for each probeset identifier were
imported into Ingenuity Pathways Analysis (IPA; Inge-
nuity
® Systems, http://www.ingenuity.com) to identify
the canonical pathways, biological functions, and net-
works of genes significantly affected by sarin-induced
seizure. Biological functions are categories that genes
are classified into based on their cellular or physiological
role in a healthy or diseased organism. Genes may be
classified into more than one biological function. A
canonical pathway is a well-established signaling or
metabolic pathway that is manually curated on the basis
of published literature. Canonical pathways are fixed
prior to data input and do not change upon data input.
Networks are distinct from canonical pathways in that
they are built de novo from input data based on known
molecular interactions identified in the published scien-
tific literature. To identify canonical pathways that were
most significant to the dataset, molecules that met the
designated p-value cutoff (≤ 0.05) and were associated
with a canonical pathway in Ingenuity’s Knowledge Base
were considered for the analysis. The significance of the
association between the dataset and the canonical path-
way was measured in two ways: 1) A ratio of the num-
ber of molecules from the data set that mapped to the
pathway divided by the total number of molecules that
mapped to the canonical pathway was displayed. 2)
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mining the probability that the association between the
genes in the dataset and the canonical pathway was
explained by chance alone. To determine networks of
genes significantly affected by sarin exposure, molecules
were overlaid onto a global molecular network devel-
oped from information contained in Ingenuity’sK n o w l -
edge Base. Networks of molecules were then
algorithmically generated based on their connectivity.
The Functional Analysis of a network identified the bio-
logical functions and/or diseases that were most signifi-
cant to the molecules in the network. The network
molecules associated with biological functions and/or
diseases in Ingenuity’s Knowledge Base were considered
for the analysis. Right-tailed Fisher’se x a c tt e s tw a su s e d
to calculate a p-value determining the probability that
each biological function and/or disease assigned to that
network is due to chance alone.
Multiplexed RT-PCR
The GenomeLab Gene Expression Profiler (GeXP; Beck-
man Coulter, Inc., Brea, CA) genetic analysis system was
used to measure the expression levels of 21 differentially
expressed cytokines or chemokines (see Additional File
1) by multiplexed RT-PCR to validate the microarray
data. Primers were designed using the eXpress Designer
module of the GenomeLab eXpress Profiler software,
with each primer consisting of 20 nucleotides of gene-
specific sequence as well as a universal primer sequence.
RT-PCR product sizes ranged from 151 to 351 nt with a
7-nt minimum separation size between each fragment
(see Additional File 1). The custom multiplexed panel
also contained glyceraldehyde 3-phosphate dehydrogen-
ase (GAPDH) for normalization and an internal control
gene (kanamycin resistance, Kan
r).
RNA samples used in the microarray experiment and
the GenomeLab GeXP Start Kit (Beckman Coulter, Inc.)
were used for the RT-PCR reactions according to the
manufacturer’s protocol. The custom multiplex was first
optimized by reverse primer dilution to attenuate the
gene signals that were close to or above the linear detec-
tion limit of the GeXP system detector (130,000 RFU in
raw data or 120,000 RFU in analyzed data) and to bal-
ance the signal of each peak within the multiplex reac-
tion. The final concentrations of the reverse primers
within the multiplex are shown in Additional File 2.
Fifty nanograms of total RNA was reverse transcribed
with the optimized reverse primer multiplex. Subse-
quently, 9.3 μl of cDNA from each RT reaction was
transferred to the PCR reaction mix containing 20 nM
of the forward primer set multiplex. All experiments
included “no template” (i.e. without RNA) and “no
enzyme” (i.e. without reverse transcriptase) negative
controls to confirm the absence of peaks at the expected
target sizes.
The fluorescently-labeled PCR products were diluted
1:20 in 10 mM Tris-HCl (pH 8), and 1 μl of each dilu-
tion was added to 38.5 μl sample loading solution along
with 0.5 μl DNA size standard-400 (GenomeLab GeXP
Start Kit). The GeXP system was then used to separate
the amplified PCR products based on size by capillary
gel electrophoresis and to measure their fluorescent dye
signal strength in arbitrary units (A.U.) of optical fluor-
escence, which is the fluorescent signal minus back-
ground. The multiplexed RT-PCR data were initially
analyzed using the Fragment Analysis module of the
GenomeLab GeXP system software, followed by the
eXpress Analysis module of the eXpress Profiler soft-
ware. First, the length or size of the products was deter-
mined using the Fragment Analysis module. The
fragment data, peak height, and peak area information
was then imported into the analysis module of the
eXpress Profiler software where the fragments were
compared to the expected PCR product sizes to identify
each transcript.
The expression of each gene within a sample was nor-
malized to GAPDH expression to minimize inter-capil-
lary variation, and the normalized intensity of each
replicate (n ≥ 3) was used to calculate an average inten-
sity of each sample group (i.e. control or sarin-induced
seizure at each time point). The fold expression differ-
ence between control and sarin-induced seizure samples
was then evaluated for all genes at each time point and
compared to the fold expression changes obtained by
microarray analysis.
Results
Clinical manifestations of sarin exposure
Male Sprague-Dawley rats were challenged with 1 ×
LD50 sarin or saline (as control) as described under
Materials and Methods. EEG monitoring showed that
seizures were induced in approximately 50% of the
sarin-exposed animals, with a mean latency of 10.2 min.
Behavioral seizure intensity was scored using a modified
Racine scale [14]. The amount of moderate and severe
toxic signs exhibited by sarin-exposed seizing animals
was significantly greater (p < 0.0001) than their controls,
with the control animals having an average toxic signs
score of 0.08 and the seizing animals having an average
score of 10.88 (Spradling et al., submitted).
Transcriptional analysis reveals gene expression profile
differences correlated with brain region and time
following seizure onset
Total RNA was isolated from the amygdala, hippocam-
pus, septum, and thalamus and processed for
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four brain regions and piriform cortex (Spradling et al.,
submitted) were normalized using the RMA algorithm
[ 1 6 ]a n da n a l y z e db yP C A( F i g u r e1 )[ 1 7 ]t or e d u c et h e
complexity of the multi-dimensional dataset. The result-
ing three-dimensional plot identified brain region type
and time after seizure onset (0.25, 1, 3, 6, or 24 h) as
major sources of variability within the dataset. Each
Figure 1 Principal component analysis reveals sample partitioning based on brain region and time following seizure onset.R a t
amygdala, hippocampus, piriform cortex, septum, and thalamus were collected at the specified times after seizure onset and processed for
oligonucleotide microarray analysis. The raw signal intensities were normalized using the RMA algorithm and visualized using PCA to identify major
sources of variability in the data. Each point on the PCA represents the gene expression profile of an individual animal. Point shape corresponds to
exposure condition, point color corresponds to the time after seizure onset at which the tissue was collected, and point size indicates absence or
occurrence of sarin-induced seizure. Ellipsoids highlight partitioning of samples based on brain region (A) and time point following seizure onset at
which the tissues were collected (C). The principal components in the three-dimensional graph represent the variability in gene expression levels
seen within the dataset. Principal component 1 (PC#1, x-axis) accounts for 17.10% of the variability in the data; PC#2 (y-axis) represents 12.00% of
the variability; and PC#3 (z-axis) represents 9.35% of the variability in gene expression levels seen within the dataset.
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of an individual animal, and the distance between any
two points is directly related to the similarity between
those two samples. Therefore, samples that are near
each other in the three-dimensional plot have a similar
transcriptional profile while those that are further apart
have dissimilar transcriptional profiles. The PCA high-
lights differences in gene expression from 0.25 h to 24 h
following seizure onset. Ellipsoids reveal partitioning of
samples based on brain region (Figure 1A, B) and time
following seizure induction (Figure 1C, D). The amyg-
dala, hippocampus, piriform cortex, and septum samples
from sarin-exposed animals clearly partition away from
controls and cluster together based on time after seizure
onset, with the 24-h seizing animals separated the furth-
est from controls. This pattern is not seen as clearly in
the thalamus samples. However, when the thalamus
samples are viewed in the three-dimensional plot alone
(excluding the other brain regions), this same pattern
becomes more visible (data not shown).
Canonical pathways associated with inflammation are
significantly altered in sensitive brain regions of sarin-
exposed seizing rats
The normalized microarray data was filtered based on
brain region, and a two-way interaction ANOVA was
performed to identify genes significantly altered based
on exposure (saline or sarin) and time after seizure
onset. The calculated p-values from each ANOVA were
then imported into IPA to identify the canonical path-
ways most affected by sarin-induced seizure in each
brain region over the 24-h time course. The top 800
genes that met the p-value cutoff (≤ 0.05) and were
associated with a canonical pathway in the IPA Knowl-
edge Base were considered for each analysis. Significant
changes in gene expression were seen in all five brain
regions following seizure occurrence, with the greatest
effects in the piriform cortex (p value cutoff ≤ 1.650 ×
10
-8; Additional File 3), hippocampus (p ≤ 1.75 × 10
-8;
Additional File 4), and amygdala (p ≤ 2.800 × 10
-7;
Additional File 5). Fewer significantly altered genes were
seen in the septum (p ≤ 1.235 × 10
-5; Additional File 6)
and thalamus (p ≤ 8.950 × 10
-5; Additional File 7).
Gene ontology analysis revealed numerous canonical
pathways that were significantly altered by sarin-induced
seizure in all five brain regions. Those that were signifi-
cantly affected in at least one brain region are shown in
an additional table (see Additional File 8). Pathways
highlighted in pink indicate those that were significantly
affected by nerve agent-induced seizure in the corre-
sponding brain region but not across all five regions
examined, grey indicates pathways detected but not sig-
nificant, and white indicates pathways not detected in
the analyses. Some canonical pathways associated with
an inflammatory response were significant across all five
brain regions. These pathways are highlighted in red
and include: ataxia telangiectasia mutated protein
(ATM) signaling, CD40 signaling, interleukin (IL)-10
signaling, IL-6 signaling, macrophage migration inhibi-
tory factor (MIF) regulation of innate immunity, role of
double-stranded RNA-activated protein kinase (PKR) in
interferon induction and antiviral response, toll-like
receptor signaling, and triggering receptor expressed on
myeloid cells 1 (TREM1) signaling. To analyze these
pathways over the 24-h time course, each brain region
dataset was filtered based on time. A one-way ANOVA
was then performed to identify genes significantly chan-
ged in each brain region at each time point based on
exposure (sarin vs saline). As detailed above, the p-value
and geometric fold change for each probeset ID were
imported into IPA, and the top 800 genes were consid-
ered for each analysis. The significance of the associa-
tion between the dataset and the canonical pathway was
calculated using Fisher’se x a c tt e s t ,a n dt h e- l o go ft h e
p-value was graphed for each time point to show the
pathway alterations over time in each brain region (Fig-
ure 2).
Pro-inflammatory cytokines appear in many of the sig-
nificantly altered pathways; therefore, we examined the
transcriptional profiles of these significantly altered
genes. We found that sarin-induced seizure up-regulates
the expression of tumor necrosis factor-a (TNF-a) in all
five brain regions examined. TNF-a expression is
induced as early as 0.25 h after seizure onset, peaks at 3
h, and returns to near control levels at 24 h (Figure 3).
IL-6 is also up-regulated in all five brain regions. How-
ever, IL-6 expression peaks at 3 h and drops at 6 h in
all brain regions. Expression then increases at 24 h fol-
lowing seizure onset in all regions except the thalamus
(Figure 4). Sarin-induced seizure also up-regulates the
expression of IL-1b in all five brain regions examined.
During the 24-h time course, IL-1b expression peaks at
1 h in the amygdala, hippocampus, and thalamus, while
it peaks at 3 h in the septum and at 24 h in the piriform
cortex. Expression returns to near control levels in the
hippocampus, septum, and thalamus, while it stays
nearly the same in the amygdala. IL-1b transcript level
is increasing in the piriform cortex at our latest time
point of 24 h (Figure 5).
We identified significantly altered canonical pathways
unique for each brain region in sarin-exposed seizing
animals. To further characterize these pathways, we fil-
t e r e dt h ed a t ab a s e do nt i m e ,a n da nA N O V Aw a sp e r -
formed to identify genes significantly altered based on
exposure (saline or sarin) at each time point following
seizure onset. The unique pathways identified in the
amygdala were apoptosis signaling; induction of apopto-
sis by HIV1; karatan sulfate biosynthesis; and role of
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arthritis (Additional File 9). When the data was analyzed
at individual time points, we found that apoptosis sig-
naling was significant at 6 h; induction of apoptosis by
HIV1 was significant at 3 and 6 h; karatan sulfate bio-
synthesis was significant at 0.25, 3, and 6 h; and role of
osteoblasts, osteoclasts, and chondrocytes in rheumatoid
arthritis was not significant at any of the time points
analyzed. The unique pathways identified in the hippo-
campus were acute myeloid leukemia signaling; hypoxia
signaling in the cardiovascular system; neuroprotective
role of thimet oligopeptidase 1 (THOP1) in Alzheimer’s
disease; retinoic acid mediated apoptosis signaling; thyr-
oid cancer signaling; and urea cycle and metabolism of
amino groups (Additional File 10). When the data were
analyzed at individual time points, we found that acute
myeloid leukemia signaling and thyroid cancer signaling
were significant at 3 h; urea cycle and metabolism of
amino groups was significant at 24 h; and hypoxia sig-
naling in the cardiovascular system was significant at 1,
3, and 24 h after seizure onset. Neuroprotective role of
THOP1 in Alzheimer’s disease and retinoic acid
mediated apoptosis signaling were not significant at any
of the individual time points examined. For the piriform
cortex, unique pathways included extracellular receptor
kinase/mitogen-activated protein kinase (ERK/MAPK)
signaling; fibroblast growth factor (FGF) signaling; G-
protein coupled receptor signaling; glioma invasiveness
signaling; glycerophospholipid metabolism; IL-1 signal-
ing; neuropathic pain signaling in dorsal horn neurons;
peroxisome proliferator-activated receptor-a/retinoid ×
receptor-a (PPARa/RXRa) activation; and taurine and
hypotaurine metabolism (Additional File 11). When ana-
lyzed at individual time points, we found that G-protein
coupled receptor signaling and PPARa/RXRa activation
were significant at 1 h; glioma invasiveness signaling
and taurine and hypotaurine metabolism were signifi-
cant at 24 h; ERK/MAPK signaling was significant at 1
and 24 h; and IL-1 signaling was significant at 3 and 6
h. FGF signaling, glycerophospholipid metabolism, and
neuropathic pain signaling in dorsal horn neurons were
not significant at any time point analyzed. The only
unique pathway identified in the septum was human
embryonic stem cell pluripotency (Additional File 12),
which was significant only at 24 h when analyzed by
individual time points. The largest number of unique
pathways was identified in the thalamus. The 24 canoni-
cal pathways identified as being significant only in the
Figure 2 Canonical pathways significantly altered in all five brain regions of sarin-exposed seizing animals. A one-way ANOVA was
performed to identify genes significantly changed in each brain region at each time point based on exposure (sarin vs. saline). The p-value and
geometric fold change for each probeset ID were imported into IPA to identify the biological functions and canonical pathways most
significantly affected by sarin-induced seizure at each time point. The top 800 genes that met the p-value cutoff (≤ 0.05) and were associated
with a canonical pathway in the IPA Knowledge Base were considered for the analysis. The significance of the association between the dataset
and the canonical pathway was calculated using Fisher’s exact test. The -log of the p-value is graphed for each time point, with a threshold of
0.05 (or 1.3 when expressed as -log(p-value)) marked by an asterisk. The range of the y-axis was formatted the same to facilitate comparison
across all the graphs in the figure.
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feron-regulatory factor (IRF) by cytosolic pattern recog-
nition receptors; aryl hydrocarbon receptor signaling;
autoimmune thyroid disease signaling; B cell receptor
signaling; chronic myeloid leukemia signaling; colorectal
cancer metastasis signaling; complement system; cross-
talk between dendritic cells and natural killer cells; eico-
sanoid signaling; estrogen-dependent breast cancer
signaling; glioblastoma multiforme signaling; glycosphin-
golipid biosynthesis-neolactoseries; granulocyte-macro-
phage colony-stimulating factor (GM-CSF) signaling;
iCOS-iCOSL signaling in T helper cells; IL-8 signaling;
molecular mechanisms of cancer; nuclear factor kappa-
light-chain-enhancer of activated B cells (NF-B) signal-
ing; p53 signaling; platelet-derived growth factor (PDGF)
signaling; phospholipase C signaling; primary immuno-
deficiency signaling; renal cell carcinoma signaling; role
of nuclear factor of activated T cells (NFAT) in
regulation of the immune response; and vitamin D
receptor/retinoic acid × receptor (VDR/RXR) activation
(Additional File 13). When the data were analyzed at
individual time points, we found that primary immuno-
deficiency signaling was significant at 6 h; autoimmune
thyroid disease, glioblastoma multiforme signaling,
iCOS-iCOSL signaling in T helper cells, and phospholi-
pase C signaling were significant at 24 h; estrogen-
dependent breast cancer signaling was significant at 0.25
and 3 h; aryl hydrocarbon receptor signaling was signifi-
cant at 3 and 6 h; B cell receptor signaling was signifi-
cant at 0.25, 6, and 24 h; PDGF signaling was significant
at 1, 3, and 6 h; VDR/RXR activation was significant at
1, 6, and 24 h; crosstalk between dendritic cells and nat-
ural killer cells was significant at 3, 6, and 24 h; p53 sig-
naling was significant at 0.25, 3, 6, and 24 h; and
molecular mechanisms of cancer was significant at 1, 3,
6, and 24 h following seizure onset. The remaining
Figure 3 Sarin-induced seizure up-regulates the expression of TNF-a in all five brain regions examined. Brain tissues were collected at
0.25, 1, 3, 6, and 24 h after seizure onset and processed for oligonucleotide microarray analysis. TNF-a expression was induced as early as 0.25 h
following seizure onset, peaked at 3 h, and returned to near control levels by 24 h after seizure onset.
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Page 8 of 21pathways were not significantly altered in the thalamus
at any individual time point following sarin-induced sei-
zure onset.
Canonical pathways and networks of genes significantly
altered across all brain regions from sarin-exposed
seizing animals
Significant genes (p ≤ 0.05) from the two-way interac-
tion ANOVA for each brain region were compared
using a Venn diagram, and the top 800 overlapping
genes that mapped to canonical pathways in the IPA
K n o w l e d g eB a s ew e r ea n a l y z e d( p ≤ 2.380 × 10
-4;s e e
Additional File 14). The pathways that were significantly
affected across all five brain regions are shown in Figure
6( p ≤ 0.05, Fisher’s exact test). For de novo network
generation, these same 800 genes were overlaid onto a
global molecular network developed from information
within the IPA Knowledge Base. The networks were
then algorithmically generated based on their connectiv-
ity. The six de novo networks identified as being most
significantly affected in all five brain regions from sarin-
exposed seizing animals are shown in Figures 7, 8, 9, 10,
11 and 12. The first network of genes is built around
the pro-inflammatory cytokine TNF-a and is associated
with inflammatory response, cellular movement, and
hematological system development and function (Figure
7). The second significant network is built around trans-
forming growth factor-beta 1 (TGFb1) and is associated
with cell-to-cell signaling and interaction, hematological
system development and function, and immune cell traf-
ficking (Figure 8). The third significant network is built
around tumor protein p53 (TP53) and caspase 9
(CASP9). This network is associated with cell morphol-
ogy, cell death, and organismal survival (Figure 9). The
fourth significant network is built around IL-6 and is
associated with cellular movement, inflammatory
Figure 4 Sarin-induced seizure up-regulates the expression of IL-6 in all five brain regions examined. Tissues were collected at 0.25, 1, 3,
6, and 24 h after seizure onset and processed for oligonucleotide microarray analysis. IL-6 expression peaked at 3 h and decreased at 6 h in all
brain regions. Expression then increased at 24 h after seizure onset in the amygdala, hippocampus, piriform cortex, and septum. IL-6 expression
appeared to level off after 6 h in the thalamus.
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ure 10). The fifth and sixth significant networks are not
built around a specific molecule. The fifth network is
associated with lipid metabolism, small molecule bio-
chemistry, and vitamin and mineral metabolism (Figure
11), and the sixth network is associated with behavior,
nervous system development and function, and cellular
growth and proliferation (Figure 12).
Multiplexed RT-PCR validation of microarray analysis data
The GeXP genetic analysis system was used to validate a
subset of differentially expressed genes in each of the
four brain regions. The capillary electrophoresis-based
system was used to separate multiplexed RT-PCR reac-
tion products to compare the expression levels of 21
inflammatory cytokines and chemokines in all of the
RNA samples. The subset of genes showed relative dif-
ferences in expression level following sarin-induced
seizure that corresponded to expression changes seen in
the microarray analysis (see Additional Files 15, 16, 17,
18).
For the amygdala (Additional File 15), the results from
both methods showed IL-1a,C C L 4 ,T N F - a, CCL3, and
CCL17 expression up-regulated at all five time points
(0.25, 1, 3, 6, and 24 h), peaking at 3 h after seizure
onset (IL-1a, CCL4, TNF-a, and CCL3) or 6 h after sei-
zure onset (CCL17). CXCL1, CCL7, CCL2, and IL-1ß
were also up-regulated at all five time points using both
methods. Secretogranin-2 (SCG2), nicotinamide phos-
phoribosyltransferase (Nampt), and CXCL16 peaked at 6
h after seizure onset before dropping slightly at 24 h in
both analyses. Using both technologies, sprouty-related
EVH1 domain containing 2 (SPRED2), secreted phos-
phoprotein-1 (SPP1), and IL-18 expression levels were
down-regulated at 0.25 h and 1 h but up-regulated for
the remainder of the time course. IL-6 was also slightly
Figure 5 Sarin-induced seizure up-regulates the expression of IL-1b in all five brain regions examined. Tissues were collected at 0.25, 1,
3, 6, and 24 h after seizure onset and processed for oligonucleotide microarray analysis. IL-1b expression peaked at 1 h in the amygdala,
hippocampus, and thalamus, while it peaked at 3 h in the septum and at 24 h in the piriform cortex. The expression levels decreased nearer to
control level in the hippocampus, septum, and thalamus, while it remained approximately the same in the amygdala. However, IL-1b transcript
level was increasing in the piriform cortex at our latest time point of 24 h.
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Page 10 of 21Figure 6 Canonical pathways significantly altered across all examined brain regions of sarin-exposed seizing animals. The dataset was
filtered on brain region (amygdala, hippocampus, piriform cortex, septum, or thalamus), and a two-way interaction ANOVA was used to identify
genes most significantly altered in each brain region based on exposure (saline or sarin) and time after seizure onset. The significant genes from
each ANOVA (p-value ≤ 0.05) were compared using a Venn diagram, and the top 800 overlapping genes that mapped to canonical pathways in
the IPA Knowledge Base were analyzed. The pathways that were significantly affected across all five brain regions are shown (p < 0.05, Fisher’s
exact test), with a threshold of 0.05 (or 1.3 when expressed as -log(p-value)) marked by an asterisk.
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Page 11 of 21down-regulated at 0.25 h and up-regulated for the
remainder of the time course with peak expression
levels at 3 and 24 h. Using both methods, CXCL10 was
down-regulated at 1 and 24 h after seizure onset with
peak expression at 6 h post-seizure onset. In both ana-
lyses, cardiotrophin-1 (CTF1) expression decreased over
the 24-h time course, and CXCL12 was down-regulated
t h r o u g h o u tt h e2 4 - ht i m ec o u r s ew i t ht h el a r g e s t
decrease in expression at 24 h after seizure onset. Ciliary
neurotrophic factor (CNTF) and MIF displayed different
patterns of expression between the two methods. Using
microarray analysis, CNTF expression increased from
0.25 to 3 h, dropped at 6 h, and peaked at 24 h after sei-
zure onset. However, using multiplex RT-PCR, CNTF
increased from 0.25 to 6 h and dropped at 24 h. MIF
expression decreased through o u tt h et i m ec o u r s eu s i n g
both methods with the exception of a slight increase at
6 h using multiplex RT-PCR.
For the hippocampus (Additional File 16), the results
from both methods showed an up-regulation of CCL4
and CCL2 expression at all five time points. TNF-a,
CXCL1, CCL3, and IL-1ß were also up-regulated at all
time points using both methods; however, the degree of
expression increase was not recorded for some time
points using multiplex RT-PCR because the transcript
levels in the control samples were too low to be
detected by the instrument. Using both techniques,
CXCL10 was up-regulated at all time points during the
time course except for 1 h after seizure onset. CXCL16
was also up-regulated at all time points except 1 h post-
Figure 7 Seizure-induced alteration of inflammatory response, cellular movement, and hematological system development and
function gene network. The dataset was filtered on brain region (amygdala, hippocampus, piriform cortex, septum, or thalamus), and a two-
way interaction ANOVA was used to identify the genes most significantly altered in each region based on exposure (saline or sarin) and time
after seizure onset. The significant genes from each ANOVA (p-value ≤ 0.05) were compared using a Venn diagram, and the top 800 overlapping
genes that mapped to canonical pathways in the IPA Knowledge Base were overlaid onto a global molecular network developed from
information within the IPA Knowledge Base. The networks were then algorithmically generated based on their connectivity. Genes are
represented as nodes of various shapes to represent the functional class of the gene product, and the biological relationship between two
nodes is represented as a line. The intensity of the node color indicates the degree of differential expression.
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sion increase at 6 h was not determined using multiplex
RT-PCR due to control levels not being detected. IL-1a
expression was up-regulated at all five time points using
multiplex RT-PCR, but appeared to be down-regulated
at 0.25 and 24 h using microarray analysis. Using both
methods, SCG2 and SPP1 were down-regulated at 0.25
h and up-regulated for the remainder of the time
course. CCL7 was also down-regulated at 0.25 h and
up-regulated for the remainder of the time course using
microarray analysis, but CCL7 expression appeared to
be up-regulated at all five time points using multiplex
RT-PCR. IL-6 expression was down-regulated at 0.25
and 1 h and increased over the 24-h time period exam-
ined using multiplexed RT-PCR. Using microarray ana-
lysis, IL-6 expression levels were slightly altered at 0.25
and 1 h, and then up-regulated at 3, 6, and 24 h.
SPRED2 expression peaked at 6 h using both methodol-
ogies but appeared to be more down-regulated using
multiplex RT-PCR. CTF1 expression appeared to be
down-regulated at all time points using microarray ana-
lysis. It was also down-regulated at all time points
except 0.25 h using multiplex RT-PCR. The degree of
CTF1 expression decrease was not recorded for 6 and
24 h using multiplex RT-PCR because the transcript
levels in the sarin-exposed seizure samples were too low
to be detected by the instrument. CNTF, CXCL12, MIF,
Nampt, and IL18 expression varied between the two
methods. Using microarray analysis, CNTF appeared to
be down-regulated at 0.25 h and up-regulated for the
remainder of the time course. Using multiplex RT-PCR,
CNTF expression appeared to be down-regulated at
0.25, 1, and 6 h, and it appeared to be up-regulated at 3
and 24 h post-seizure onset. CXCL12 and MIF
Figure 8 Seizure-induced alteration of cell-to-cell signalling/interaction, hematological system development/function, and immune cell
trafficking gene network.
Spradling et al. Journal of Neuroinflammation 2011, 8:84
http://www.jneuroinflammation.com/content/8/1/84
Page 13 of 21expression decreased over the 24-h time course using
microarray analysis. Using multiplex RT-PCR, CXCL12
was down-regulated at 0.25 and 1 h and up-regulated at
3, 6, and 24 h. MIF expression was up-regulated at 0.25,
3, and 6 h and down-regulated at 1 and 24 h. Nampt
expression was up-regulated at all five time points
except 0.25 h using microarray analysis and 6 h using
multiplex RT-PCR. IL-18 expression was down-regu-
lated at the beginning (0.25 and 1 h) of the time course
and down-regulated at 3-24 h using microarray analysis.
However, IL-18 expression was up-regulated at 0.25 and
1 h and down-regulated at 3-24 h post-seizure onset.
CCL17 expression also varied between the two methods.
Using microarray analysis, it appeared to be down-regu-
l a t e da t0 . 2 5a n d1hb u tu p - r e g u l a t e da t3 - 2 4h .U s i n g
multiplex RT-PCR, CCL17 appeared to be up-regulated
at all time points except 6 h post-seizure onset. The
expression level was not detected in the sarin-exposed
seizure hippocampal samples at 6 h, so it appeared to
be down-regulated at this time point.
For the septum (Additional File 17), the results from
both methods showed an up-regulation of SCG2, SPP1,
CCL4, TNF-a, CCL7, CCL2, CCL3, and IL-1ß at all five
time points while CXCL12 and CTF1 were down-regu-
l a t e df o l l o w i n gs a r i n - i n d u c e ds e i z u r e ,e x c e p ta tt h ee a r -
liest time point of 0.25 h. Using both methods, IL-1a
expression peaked at 3 h; SPRED2, IL-18, CXCL10, and
CCL17 peaked at 6 h; and CXCL16 peaked at 24 h after
seizure onset. CXCL1 expression was up-regulated at all
five time points and peaked at 3 h using microarray ana-
lysis, but expression changes were not collected using
multiplex RT-PCR because transcript levels in the con-
trol samples were too low to be detected by the instru-
ment. Using both methods, IL-6 expression appeared to
be up-regulated at 3 h, decreased at 6 h, and then
peaked at 24 h post-seizure onset. The expression pat-
tern for CNTF, MIF, and Nampt appeared to slightly
vary between the two methodologies. CNTF expression
appeared to be slightly down-regulated at 0.25 and 6 h
using microarray analysis; however, expression was up-
Figure 9 Seizure-induced alteration of cell morphology, cell death, and organismal survival gene network.
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down-regulated at 0.25 and 24 h using both methods,
but it was also slightly down-regulated at 1 h using
microarray analysis and at 3 h using multiplex RT-PCR.
Nampt expression appeared to peak at 3 h and slightly
decrease at 6 and 24 h using microarray analysis while it
appeared to peak at 24 h using multiplex RT-PCR.
For the thalamus (Additional File 18), the results from
both methods showed CCL4, TNF-a, CCL7, CCL2, and
CXCL10 expression up-regulated and CXCL12 expres-
sion down-regulated at all five time points. Nampt and
CXCL16 expression levels were also up-regulated at all
five time points using multiplexed RT-PCR, but micro-
array results showed Nampt and CXCL16 down-regu-
lated at 0.25 and 1h, respectively. CXCL1, CCL3,
CCL17, and IL-1ß expression levels were up-regulated
at all five time points using microarray analysis. Changes
in expression were not collected for some time points
using multiplex RT-PCR because transcript levels in the
control samples were too low to be detected by the
instrument, and expression levels were up-regulated at
the other time points where data was collected. There-
fore, the multiplex RT-PCR data correlates with that
from the microarray analysis. IL-1a and IL-6 expression
peaked at 3 h after seizure onset using both methods.
IL-1a appeared to be down-regulated at 0.25 and 24 h,
and IL-6 appeared to be down-regulated at 0.25 and 1 h
after seizure onset using multiplex RT-PCR. SPRED2
and SCG2 expression peaked at 6 h, but appeared to be
more down-regulated using multiplex RT-PCR. IL-18
expression increased over the 24-h time course with
peak expression at 24 h. SPP1 expression levels
decreased at 1 h and then continually increased from 3
to 24 h after seizure onset. CNTF and MIF showed
slightly different expression patterns using the two dif-
ferent methods. CNTF expression was down-regulated
a tt h ef i r s tt h r e et i m ep o i n t sa n du p - r e g u l a t e da t6h
using both methods. However, CNTF appeared to be
up-regulated at 24 h using microarray analysis and
down-regulated at 24 h using multiplex RT-PCR. Using
Figure 10 Seizure-induced alteration of cellular movement, inflammatory response, and cell-to-cell signalling/interaction gene
network.
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Page 15 of 21microarray analysis, MIF expression appeared to be up-
r e g u l a t e da t0 . 2 5a n d3h ,d o w n - r e g u l a t e da t1a n d6h ,
and unchanged at 24 h. Using multiplex RT-PCR, MIF
expression was up-regulated at 0.25 and 1 h, down-
r e g u l a t e da t3a n d6h ,a n dt h e nu p - r e g u l a t e da g a i na t
24 h post-seizure onset. CTF1 expression also appeared
to differ between the two methods. Using microarray
analysis, CTF1 appeared to be down-regulated at the
beginning (0.25 h) and end (24 h) of the time course
a n du p - r e g u l a t e da t1 ,3 ,a n d6ha f t e rs e i z u r eo n s e t .
Using multiplex RT-PCR, expression data was not col-
lected for CTF1 at 0.25 h because transcript levels in
the control samples were too low to be detected by the
GeXP instrument but was up-regulated at 1, 3, and 24 h
and down-regulated at 6 h after seizure onset.
Although there are some variations in expression data
between the two methods, the overall expression levels
of the examined inflammatory cytokines and chemo-
kines were in close agreement using the two different
methodologies. The differences in expression levels can
easily arise from variation in quantitative methodology.
Because these two technologies are different, slight
differences in expression between the two methods are
expected, but overall the data between the microarray
analysis and multiplexed PCR analysis are in close
agreement.
Discussion
In this study, we performed gene expression profiling to
assess the temporal transcriptional changes associated
with sarin-induced seizure. Comparison of the transcrip-
tional profiles of five nerve agent-sensitive rat brain
regions (amygdala, hippocampus, piriform cortex, sep-
tum, and thalamus) indicated the presence of a robust
inflammatory response in sarin-exposed seizing animals.
In agreement with previously reported findings
[13,18-26], we observed a rapid activation of the innate
immune response that persisted throughout the 24-h
time period examined. Therefore, we predict that pro-
inflammatory cytokines and their signaling pathways
could potentially mediate some of the molecular and
structural changes observed after nerve agent-induced
seizure activity. Because current countermeasures do
not fully prevent neuropathology, particularly in
Figure 11 Seizure-induced alteration of lipid metabolism, small molecule biochemistry, and vitamin/mineral metabolism gene
network.
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rorist attack), identifying therapeutic targets that med-
iate the cascade of secondary events leading to brain
damage and functional impairment is critical.
Our findings, which are in agreement with previous
studies of soman-induced brain damage [1,11,18,20,27],
indicate that sarin toxicity correlates with the develop-
ment and duration of seizures. Significant changes in
gene expression were seen in all five brain regions fol-
lowing seizure occurrence with the greatest effects in
the piriform cortex, which is in agreement with the find-
ings of Lemercier at al. [28] and McDonough et al. [10].
However, it should be noted that a higher vulnerability
to nerve agent-induced brain damage has been observed
in other cerebral regions of other animal models. These
highly susceptible brain regions include the thalamus in
mice [11], the amygdala in guinea pigs [27], and the
frontoparietal cortex and cerebellum in monkeys
[29,30]. This variability may be due to interspecies dif-
ferences in functional anatomy and/or differences in
study design. However, the five brain regions examined
in our study are nerve agent sensitive regions of the rat
brain. Therefore, we examined each of these brain
regions for common nerve agent-induced pathways to
explore molecular mechanisms involved in nerve agent-
induced brain injury.
Gene ontology analysis revealed numerous canonical
pathways that were significantly altered by sarin-induced
seizure in the five regions of the rat brain examined in
this study. The pathways that were significantly affected
in all five brain regions are known to be associated with
an inflammatory response and include many pro-inflam-
matory cytokines. These pathways include ATM signal-
ing, CD40 signaling, IL-10 signaling, IL-6 signaling, MIF
regulation of innate immunity, role of double-stranded
PKR in interferon induction and antiviral response, toll-
like receptor signaling, and TREM1 signaling. Further-
more, pro-inflammatory cytokines were among the de
novo networks identified as most significantly affected in
all five brain regions from sarin-exposed seizing animals.
Two of the top six networks were associated with an
inflammatory response. One network of genes was built
around TNF-a as a central node and the other around
IL-6 as a central node.
Figure 12 Seizure-induced alteration of behavior, nervous system development/function, and cellular growth/proliferation gene
network.
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lular communication and play a significant role in the
pathological processes involved in various brain diseases,
such as SE [31-35]. Although picomolar or low nanomo-
lar ranges of cytokines enhance neuronal survival, higher
concentrations have deleterious effects on neuronal via-
bility [36]. The findings presented in this study are in
agreement with the observed inflammatory response
previously reported following nerve agent intoxication
[13,18-26], as well as in other models of seizure induc-
tion [33,37]. Although these studies all show an up-reg-
ulation of inflammatory cytokines, it should be noted
that the expression patterns of individual cytokines vary
from study to study. These variations likely stem from
differences in the nerve agent tested (sarin vs soman),
animal models used (rats vs mice), pharmacological
treatments given, and, maybe most importantly, seizure
intensity [24]. For example, Williams et al. [19] and
Dhote et al. [24] employed quantitative real time-PCR
to characterize the temporal response of inflammatory
cytokines following soman-induced seizures in rats and
mice, respectively. Williams and colleagues showed an
initial up-regulation of TNF-a mRNA in the hippocam-
pus, piriform cortex, and thalamus at their earliest time
point of 2 h after exposure. This was subsequently fol-
l o w e db ya ni n c r e a s ei nI L - 1 b and IL-6 mRNA at 6 h
after exposure. The findings of Dhote et al. [24] also
indicated a significant induction of inflammatory cyto-
kines in the whole cortex and hippocampus but not in
the cerebellum. Cytokine activation was seen as early as
1 h after exposure in the cortex with a peak response
between 6 and 24 h. However, cytokine up-regulation
was delayed to 6 h after exposure in the hippocampus
with peak expression levels observed between 24 and 48
h. Our data also show an acute up-regulation of inflam-
matory cytokines, but the temporal expression patterns
are slightly different. We observed a significant increase
in IL-1b,I L - 6 ,a n dT N F - a expression levels as early as
0.25 h following seizure onset in all five brain regions
examined. Of the three cytokines listed, IL-1b expres-
sion peaked the earliest following seizure onset and
dropped to near control levels in the hippocampus, sep-
tum, and thalamus by 24 h, whereas it appeared to be
leveling out in the amygdala and increasing in the piri-
form cortex at 24 h. It is known that IL-1b induces its
own synthesis [38], and this positive feedback loop
could enhance and extend the IL-1b response [33].
Therefore, we hypothesize that this positive feedback
loop could be a contributing factor in the greater neuro-
pathology seen in the piriform cortex of the rat model.
The peak in IL-1b expression is followed by IL-6 and
TNF-a, which both peaked at 3 h in all five brain
regions. Moynagh et al. [39] showed that IL-1b stimu-
lates the expression of NF-B, which in turn activates a
variety of genes involved in the inflammatory response
in CNS diseases [33]. Therefore, our data appear to sup-
port the role of NF-B in the neuropathology resulting
from nerve agent-induced seizures as it shows a sharp
induction by 3 h after seizure onset in all brain regions
examined (data not shown) along with IL-6 and TNF-a
expression. TNF-a expression decreased to near control
levels by 24 h in all five brain regions. However, IL-6
expression decreased at 6 h in all five brain regions and
then increased at 24 h after seizure onset in all regions
except the thalamus.
Studies have shown that nerve agent-induced seizures
initially result from AChE inhibition and overstimula-
tion of cholinergic receptors, which is followed by an
increase of excitatory amino acids (EAAs), such as glu-
tamate [1-3]. This glutamatergic hyperactivity causes an
opening of N-methyl-D-aspartate (NMDA) calcium
channels and a subsequent increase in intracellular cal-
cium [1,40,41], which in turn initiates signaling cascades
that cause neuronal death. Based on our findings and
those of other investigators, it appears that inflamma-
tory signaling pathways are an important component of
nerve agent-induced brain injury; however, the molecu-
lar mechanisms by which nerve agent-induced seizures
produce acute neuroinflammation or how this phenom-
enon contributes to the ensuing neuropathology follow-
ing exposure is still unclear. In vitro studies have shown
that pro-inflammatory cytokines play a role in glutamate
toxicity as they inhibit glial cells from taking up excess
extracellular glutamate [42]. Cytokines are thought to
further enhance this glutamatergic hyperactivity by
increasing NMDA receptor activity [43], which pro-
motes excitotoxic neuronal cell death [44,45]. Another
mechanism by which pro-inflammatory cytokines could
contribute to nerve agent toxicity involves blood-brain
barrier (BBB) function. The brain is normally isolated
f r o mt h ep e r i p h e r a li m m u n es y s t e mv i at h eB B B ;h o w -
ever, a neurotoxic insult, such as a convulsant dose of
sarin, can induce both a local and peripherally recruited
inflammatory response. BBB damage has been seen in
many neurodegenerative diseases and animal models of
seizure [46], and studies have shown that pro-inflamma-
tory cytokines including TNF-a,I L - 1 b, IL-6, and inter-
feron-l are implicated in the regulation of BBB
permeability [47-49]. For example, IL-1b can affect the
permeability of the BBB via disruption of the tight-junc-
tion organization or production of nitric oxide and
matrix metalloproteinases in endothelial cells [49]. The
data from our sarin exposure model indicate that there
could be a breakdown of the BBB as well. This was
indicated by the up-regulation of inter-cellular adhesion
molecule-1 (ICAM1) and E-selectin in all five brain
regions. These molecules are thought to be linked to
signal transduction cascades leading to junctional
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keleton, which in turn is an indicator of infiltration of
peripheral leukocytes into damaged brain regions
through the BBB [47]. We also observed a decrease in
occludin expression levels, which is one of the main
components of tight junctions, indicating a possible loss
of tight junction integrity. The findings of our study
support those of Abdel-Rahman et al. [50] who demon-
strated that a toxic dose of sarin can break down the
BBB and speculated that this disruption plays an impor-
tant role in sarin-induced cell death in the motor cor-
tex, hippocampus, and cerebellum. Furthermore,
Damodaran et al. [22,23] identified numerous BBB-
related genes that were altered at 15 min and persisted
until three months following 0.5 and 1.0 × LD50 sarin
exposure.
Conclusions
Transcriptional profiling and pathway modeling provide
a powerful approach in the development of neuropro-
tectants against nerve agente x p o s u r e .T h ef i n d i n g so f
this study are in agreement with those previously
reported and provide critical insight into the identifica-
tion of possible therapeutic targets that could potentially
provide broad-spectrum protection in areas of the cen-
tral nervous system known to be damaged by nerve
agent-induced seizure. The persistently altered expres-
sion profiles of pro-inflammatory cytokines strongly sug-
gests that they may play a role in the sequence of
molecular events leading to nerve agent-induced neuro-
pathological changes. Therefore, the antagonism of pro-
inflammatory molecules, as well as their receptors and
signaling pathways, may represent novel targets for the
development of drug therapies that would alleviate neu-
rological damage when given after the onset of seizures
and secondary responses that lead to brain injury have
begun.
Additional material
Additional file 1: Gene symbol, PCR product size, and primer
sequences used in multiplex RT-PCR assays.
Additional file 2: Concentrations of reverse primers within the RT-
PCR multiplex.
Additional file 3: Top 800 significantly altered genes in piriform
cortex post-seizure onset used for gene ontology analysis.
Additional file 4: Top 800 significantly altered genes in
hippocampus post-seizure onset used for gene ontology analysis.
Additional file 5: Top 800 significantly altered genes in amygdala
post-seizure onset used for gene ontology analysis.
Additional file 6: Top 800 significantly altered genes in septum
post-seizure onset used for gene ontology analysis.
Additional file 7: Top 800 significantly altered genes in thalamus
post-seizure onset used for gene ontology analysis.
Additional file 8: Canonical pathways significantly altered in sarin-
exposed seizing animals. A two-way interaction ANOVA was performed
to identify genes most significantly altered in each brain region based
on exposure (saline or sarin) and time after seizure onset. The top 800
genes ranked by p-value were mapped to canonical pathways in the IPA
Knowledge Base to identify molecular effects in seizing animals. Only
those canonical pathways that were significantly affected in at least one
brain region are shown (p < 0.05, Fisher’s exact test); the -log of the p-
value is shown for each pathway (1.3 = -log of 0.05). Pink indicates
detected and significant (≥ 1.3); grey indicates detected but not
significant (< 1.3); white indicates not detected. Pathways significant for
all brain regions are indicated in red.
Additional file 9: Canonical pathways significantly altered only in
the amygdala of sarin-exposed seizing animals. A two-way
interaction ANOVA was performed to identify genes significantly altered
based on exposure (saline or sarin) and time after seizure onset. The top
800 genes (ranked by p-value) that mapped to canonical pathways in
the IPA Knowledge Base were used to identify molecular effects in the
amygdala of seizing animals. The canonical pathways that were
significantly affected only in the amygdala (and not in any of the other
brain regions examined) are shown. To further characterize these
pathways, we filtered the data again based on time, and an ANOVA was
performed to identify genes significantly altered based on exposure
(saline or sarin) at each time point following seizure onset. When the
data was analyzed at individual time points, we found that apoptosis
signaling was significant at 6 h; induction of apoptosis by HIV1 was
significant at 3 and 6 h; karatan sulfate biosynthesis was significant at
0.25, 3, and 6 h; and role of osteoblasts, osteoclasts, and chondrocytes in
rheumatoid arthritis was not significant at any of the time points
analyzed. The -log of the p-value are graphed for each time point (1.3 =
-log of 0.05).
Additional file 10: Canonical pathways significantly altered only in
the hippocampus of sarin-exposed seizing animals. When the data
was analyzed at individual time points, we found that acute myeloid
leukemia signaling and thyroid cancer signaling were significant at 3 h;
urea cycle and metabolism of amino groups was significant at 24 h; and
hypoxia signaling in the cardiovascular system was significant at 1, 3, and
24 h following seizure onset. Neuroprotective role of THOP1 in
Alzheimer’s disease and retinoic acid mediated apoptosis signaling were
not significant at any of the individual time points examined.
Additional file 11: Canonical pathways significantly altered only in
the piriform cortex of sarin-exposed seizing animals. When analyzed
at individual time points, we found that G-protein coupled receptor
signaling and PPARa/RXRa activation were significant at 1 h; glioma
invasiveness signaling and taurine and hypotaurine metabolism were
significant at 24 h; ERK/MAPK signaling was significant at 1 and 24 h; and
IL-1 signaling was significant at 3 and 6 h. FGF signaling,
glycerophospholipid metabolism, and neuropathic pain signaling in
dorsal horn neurons were not significant at any time point analyzed.
Additional file 12: Canonical pathway significantly altered only in
the septum of sarin-exposed seizing animals. When analyzed at
individual time points, it was significant only at 24 h after seizure onset.
Additional file 13: Canonical pathways significantly altered only in
the thalamus of sarin-exposed seizing animals. When the data was
analyzed at individual time points, we found that primary
immunodeficiency signaling was significant at 6 h; autoimmune thyroid
disease, glioblastoma multiforme signaling, iCOS-iCOSL signaling in T
helper cells, and phospholipase C signaling were significant at 24 h;
estrogen-dependent breast cancer signaling was significant at 0.25 and 3
h; aryl hydrocarbon receptor signaling was significant at 3 and 6 h; B cell
receptor signaling was significant at 0.25, 6, and 24 h; PDGF signaling
was significant at 1, 3, and 6 h; VDR/RXR activation was significant at 1, 6,
and 24 h; crosstalk between dendritic cells and natural killer cells was
significant at 3, 6, and 24 h; p53 signaling was significant at 0.25, 3, 6,
and 24 h; and molecular mechanisms of cancer was significant at 1, 3, 6,
and 24 h after seizure onset. The remaining pathways were not
significantly altered in the thalamus at any individual time point
following sarin-induced seizure onset.
Spradling et al. Journal of Neuroinflammation 2011, 8:84
http://www.jneuroinflammation.com/content/8/1/84
Page 19 of 21Additional file 14: Top 800 significantly altered genes across all
brain regions from sarin-exposed seizing animals.
Additional file 15: Microarray analysis and multiplexed RT-PCR
show similar gene expression changes in amygdala following sarin-
induced seizure. The GeXP genetic analysis system was used to
measure the expression levels of 21 differentially expressed cytokines or
chemokines by multiplexed RT-PCR to validate the microarray data. The
expression of each gene within a sample was normalized to GAPDH
expression to minimize inter-capillary variation, and the normalized
intensity of each replicate (n ≥ 3) was used to calculate an average
intensity of each sample group (i.e. control or sarin-induced seizure at
each time point). The fold expression difference between control and
sarin-induced seizure samples is shown for each gene at each of the five
time points examined. The fold changes in expression obtained in the
microarray analysis are shown on the left, and the fold changes in
expression obtained in the multiplex PCR analysis are shown on the
right. Genes that were down-regulated following sarin-induced seizure
are shaded in green, and genes that were up-regulated following sarin-
induced seizure are shaded in red. Changes in expression were not
collected for some time points using multiplex RT-PCR because transcript
levels in the control samples were too low to be detected by the
instrument (indicated by an asterisk).
Additional file 16: Microarray analysis and multiplexed RT-PCR
show similar gene expression changes in hippocampus following
sarin-induced seizure.
Additional file 17: Microarray analysis and multiplexed RT-PCR
show similar gene expression changes in septum following sarin-
induced seizure.
Additional file 18: Microarray analysis and multiplexed RT-PCR
show similar gene expression changes in thalamus following sarin-
induced seizure.
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